Study Finds Statin Use Associated With Reduced Mortality in Multiple Myeloma

Analysis of data from the Veterans Administration Central Cancer Registry, reported in the Journal of Clinical Oncology by Sanfilippo et al, showed that statin use was associated with a reduced risk of all-cause and multiple myeloma–specific mortality in patients with multiple myeloma. Statins are active in a pathway affected by nitrogen-containing bisphosphonates, which have been associated with improved survival in multiple myeloma.

 The ASCO Post

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.